News | Atrial Fibrillation | May 09, 2016

Afib Risk Lower in Hispanics, African Americans with Heart Failure Than Whites

Large study analyzes more than 68,000 patients and illustrates interaction between heart failure and atrial fibrillation in different races and ethnicities

atrial fibrillation risk, heart failure, African Americans, Hispanics, whites, HRS 2016

May 9, 2016 — A new study presented at the Heart Rhythm Society’s 37th Annual Scientific Sessions, found that among patients with heart failure, atrial fibrillation (AF) was significantly less common among African Americans and Hispanics than among non-Hispanic whites. This study indicates a strong correlation between race and ethnicity and the development of AF for patients with heart failure.

Heart failure is a common risk factor for AF and is a major public health issue, with a prevalence of over 5.8 million in the United States, over 23 million worldwide and rising. Specifically, heart failure is more prevalent in African Americans and Hispanics than in non-Hispanic whites. The higher heart failure burden but lower prevalence of AF in African Americans compared to non-Hispanic whites is known as the “racial paradox.” However, the contribution and interaction of heart failure for AF in Hispanic minorities is largely unknown.

The study analyzes a large population of 68,022 patients between the ages of 45 and 95. Patient data from 28,489 Hispanics, 25,204 African Americans and 14,329 non-Hispanic whites was studied for the presence of AF, diagnosed using electrocardiograms (EKGs), and for the presence of heart failure, detected using diagnosis code ICD-9. Analysis was then performed to determine the independent predictive ability of heart failure by race and ethnicity to predict AF.

The prevalence of heart failure and AF varied by race and ethnicity. After adjusting for risk factors, the presence of heart failure in Hispanics and African Americans was associated with significantly lower odds of developing AF than in non-Hispanic whites. Specifically, results show African Americans and Hispanics are 23.2 percent and 26.9 percent, respectively, less likely than non-Hispanic whites to develop AF.

“Our analysis shows an independent association between race and ethnicity and atrial fibrillation in a large population with heart failure, which is something largely unknown, specifically within the Hispanic population. It’s especially interesting because, despite having many risk factors for AF, Hispanic and African American patients had a lower risk of developing AF,” said Eric H. Shulman, M.D., Montefiore Medical Center, Bronx, N.Y. “There may be an underlying genetic reason for why we saw such significant differences between these groups. Better understanding and awareness of the disparities between heart failure and atrial fibrillation by race and ethnicity will help physicians develop a more individualized approach to patient care moving forward.”

The study authors note that further research is needed to understand the interrelations of heart failure and AF in racial and ethnic minorities in order to inform prevention strategies for both adverse conditions.

For more information: www.hrsonline.org


Related Content

News | Atrial Fibrillation

Nov. 18, 2024 — Abbott recently announced new data for the Amplatzer Amulet Left Atrial Appendage (LAA) Occluder to ...

Home November 19, 2024
Home
News | Atrial Fibrillation

Oct. 18, 2024 — The Heart Rhythm Society (HRS) Board of Trustees unanimously approved the formation of Heart Rhythm ...

Home October 21, 2024
Home
News | Atrial Fibrillation

Sept. 11, 2024 — In the first national estimate in two decades, researchers at the University of California-San ...

Home September 11, 2024
Home
News | Atrial Fibrillation

July 24, 2024 — Volta Medical, a health technology company developing artificial intelligence (AI) solutions to assist ...

Home July 24, 2024
Home
News | Atrial Fibrillation

July 8, 2024 — Pulsed field ablation (PFA) is safe for treating patients with common types of atrial fibrillation (AF) ...

Home July 08, 2024
Home
News | Atrial Fibrillation

June 12, 2024 — A team of Ochsner Health cardiologists recently published an article in the Journal of the American ...

Home June 12, 2024
Home
News | Atrial Fibrillation

April 18, 2024 — New evidence-based research calls into question the conventional three-month blanking period ...

Home April 18, 2024
Home
News | Atrial Fibrillation

March 28, 2024 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson ...

Home March 28, 2024
Home
News | Atrial Fibrillation

February 27, 2024 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & ...

Home February 27, 2024
Home
News | Atrial Fibrillation

February 6, 2024 — Cortex announced the initiation of its RESOLVE-AF trial (NCT05883631), a study formally launched in ...

Home February 06, 2024
Home
Subscribe Now